BIOPOR Bioporto A/S

Share capital and votes

Share capital and votes

April 30, 2020

Announcement no. 12

Share capital and votes

Pursuant to section 32 of the Danish Capital Markets Act, BioPorto’s nominal share capital totals DKK 199,936,428 consisting of 199,936,428 shares of DKK 1.00, equivalent to 199,936,428 votes. BioPorto’s Articles of Association have been updated accordingly and are available on

For further information, please contact:

Ole Larsen, CFO

Telephone , e-mail:

About BioPorto

BioPorto is an in vitro diagnostics company that provides tests and antibodies to clinicians and researchers around the world. We use our antibody and assay expertise to transform novel research tools into clinically actionable biomarkers that can make a difference in patients’ lives. BioPorto is headquartered in Hellerup, Denmark and is listed on the NASDAQ Copenhagen stock exchange [CPH:BIOPOR].

Attachment

EN
30/04/2020

Underlying

BIOPORBioporto A/S

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bioporto A/S

 PRESS RELEASE
Free
BIOPOR BIOPORTO A/S

Fortsat fremgang på vigtige strategiske milepæle i første kvartal af 2...

Fortsat fremgang på vigtige strategiske milepæle i første kvartal af 2025. Den samlede omsætning er i overensstemmelse med forventningerne, og guidance for 2025 fastholdes. 8. maj 2025Meddelelse nr. 15                                                                          Fortsat fremgang på vigtige strategiske milepæle i første kvartal af 2025. Den samlede omsætning er i overensstemmelse med forventningerne, og guidance for 2025 fastholdes. Delårsresultat og en forretningsstatus for første kvartal 2025 København, Danmark, 8. maj 2025, (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto eller S...

May 8, 2025 1 EN
 PRESS RELEASE
Free
BIOPOR BIOPORTO A/S

Continued progress on key strategic milestones in Q1 2025. Total reven...

Continued progress on key strategic milestones in Q1 2025. Total revenue in line with expectations and guidance for 2025 maintained. May 8, 2025Announcement no. 15                                                                          Continued progress on key strategic milestones in Q1 2025. Total revenue in line with expectations and guidance for 2025 maintained. Interim results and a business update for the first quarter of fiscal 2025 Copenhagen, Denmark, May 8, 2025, (GLOBE NEWSWIRE) – BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR) today announced interim financial resul...

May 8, 2025 1 EN
 PRESS RELEASE
Free
BIOPOR BIOPORTO A/S

Tildeling af Warrants

Tildeling af Warrants 28. april 2025Meddelelse nr. 14                                                                          Tildeling af Warrants København, Danmark, den 28. april 2025 (GLOBE NEWSWIRE) – Bestyrelsen for BioPorto A/S ("BioPorto" eller "Selskabet") (CPH:BIOPOR) har i dag implementeret beslutningen fra den ordinære generalforsamling afholdt den 11. april 2025 om at udstede i alt 1.700.000 warrants som en del af vederlaget til medlemmerne af Selskabets bestyrelse. Hver warrant giver indehaveren ret til at tegne én aktie i BioPorto til en udnyttelseskurs på 1.50 kr. pr. a...

April 28, 2025 1 EN
 PRESS RELEASE
Free
BIOPOR BIOPORTO A/S

Grant of Warrants

Grant of Warrants April 28, 2025Announcement no. 14                                                                          Grant of Warrants Copenhagen, Denmark, April 28, 2025, (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR) has today implemented the resolution of the annual general meeting held on April 11, 2025 to issue a total of 1,700,000 warrants as part of the remuneration to members of the Board of Directors of the Company. Each warrant entitles the holder the right to subscribe for one share in BioPorto at an exercise price...

April 28, 2025 1 EN
 PRESS RELEASE
Free
BIOPOR BIOPORTO A/S

Ledende medarbejderes transaktioner

Ledende medarbejderes transaktioner 25. april 2025Meddelelse nr. 13                                                                          Ledende medarbejderes transaktioner I forbindelse med gennemførelsen af BioPorto A/S' rettede emission, som beskrevet i selskabsmeddelelse nr. 12, har BioPorto A/S i henhold til artikel 19 i forordning (EU) nr. 596/2014 modtaget indberetning af nedenstående transaktioner vedrørende aktier i BioPorto A/S foretaget af personer med ledelsesansvar i BioPorto A/S og/eller nærtstående til disse. 1 Nærmere oplysninger om personen med ledelsesansvar/persone...

April 25, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch